Skip to main content
Premium Trial:

Request an Annual Quote

Richard Elgen, Zach Pitluk

Richard Elgen has joined PerkinElmer as vice president and general manager of discovery and research reagents for the firm's Life and Analytical Sciences unit. Elgen joins PerkinElmer from DiscoveRx, where he served as chief scientific officer and executive vice president for research and development.

He holds a PhD in molecular pharmacology from Trent University in Nottingham, UK.



Zach Pitluk joined Gene Network Sciences as vice president of business development.

Pitluk moved to Gene Network Sciences from Definiens, where he served as the North America life sciences business manager. Previously, he spent five years at Cellomics, a Fisher Biosciences business unit. Prior to Cellomics, he held sales positions at Clontech Labs, Bristol-Myers Squibb, and ISCO.

He received his PhD in molecular biophysics and biochemistry from Yale University.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.